Why Abzena?
Our focused approach.
Erika Kovacs Ph.D. has over fifteen years of scientific research experience with a strong background in cancer biology and immunology, proficiency in both biochemical and cell-based assay development.
Erika is dedicated to contributing to Abzena’s drug discovery and development efforts in large molecule therapeutics, and advancing new modalities to fight cancer like antibody-drug conjugates.
Erika is a Doctor of Philosophy (Ph.D.) Biochemistry & Molecular Biology.
What is your biologic drug development challenge? Ask our expert today. We are ready to help.